APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Leflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Leflunomide Tablets Market Analysis and Forecast 2026-2032

Report ID 174006800227 December 2025195 pages

Choose your research edition.

Industry ResearchLeflunomide Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Leflunomide Tablets Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Leflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leflunomide Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Leflunomide Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Leflunomide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Leflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Leflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Leflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Leflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Leflunomide Tablets include Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd. and Teva Pharmaceutical Industries Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Leflunomide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Leflunomide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Leflunomide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Leflunomide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Leflunomide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Leflunomide Tablets sales, projected growth trends, production technology, application and end-user industry.

Leflunomide Tablets Segment by Company

Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.

Xiamen Lizhuo Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Meiro Pharmaceutical Co., Ltd.

Jiangsu Yabang Epson Pharmaceutical Co., Ltd.

Hebei Wansui Pharmaceutical Co., Ltd.

Fujian Huitian Biopharmaceutical Co., Ltd.

Changzhou Watson Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Sanofi

Lupin Pharmaceuticals, Inc.

Alembic Pharmaceuticals Inc.

Leflunomide Tablets Segment by Type

Generic Drugs

Original Drugs

Leflunomide Tablets Segment by Application

Hospital

Clinic

Other

Leflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Leflunomide Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Leflunomide Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leflunomide Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Leflunomide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Generic Drugs Major Manufacturers Table 3. Original Drugs Major Manufacturers Table 4. Global Leflunomide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Leflunomide Tablets Industry Trends Table 9. Leflunomide Tablets Industry Drivers Table 10. Leflunomide Tablets Industry Opportunities and Challenges Table 11. Leflunomide Tablets Industry Restraints Table 12. Global Leflunomide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Leflunomide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Leflunomide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Leflunomide Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Leflunomide Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Leflunomide Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Leflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Leflunomide Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Leflunomide Tablets Sales Market Share by Region (2021-2026) Table 21. Global Leflunomide Tablets Sales Market Share by Region (2027-2032) Table 22. Global Leflunomide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Leflunomide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Leflunomide Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Leflunomide Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Leflunomide Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Leflunomide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Leflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Leflunomide Tablets Manufacturers, Product Type & Application Table 30. Global Leflunomide Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Leflunomide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Leflunomide Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Leflunomide Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Leflunomide Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Leflunomide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Leflunomide Tablets Sales Market Share by Type (2021-2026) Table 42. Global Leflunomide Tablets Sales Market Share by Type (2027-2032) Table 43. Global Leflunomide Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Leflunomide Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Leflunomide Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Leflunomide Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Leflunomide Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Leflunomide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Leflunomide Tablets Sales Market Share by Application (2021-2026) Table 54. Global Leflunomide Tablets Sales Market Share by Application (2027-2032) Table 55. Global Leflunomide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Leflunomide Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information Table 58. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview Table 59. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 61. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Development Table 62. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information Table 63. Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview Table 64. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 66. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Development Table 67. Qilu Pharmaceutical Co., Ltd. Company Information Table 68. Qilu Pharmaceutical Co., Ltd. Business Overview Table 69. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 71. Qilu Pharmaceutical Co., Ltd. Recent Development Table 72. Meiro Pharmaceutical Co., Ltd. Company Information Table 73. Meiro Pharmaceutical Co., Ltd. Business Overview Table 74. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 76. Meiro Pharmaceutical Co., Ltd. Recent Development Table 77. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information Table 78. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview Table 79. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 81. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Development Table 82. Hebei Wansui Pharmaceutical Co., Ltd. Company Information Table 83. Hebei Wansui Pharmaceutical Co., Ltd. Business Overview Table 84. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 86. Hebei Wansui Pharmaceutical Co., Ltd. Recent Development Table 87. Fujian Huitian Biopharmaceutical Co., Ltd. Company Information Table 88. Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview Table 89. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 91. Fujian Huitian Biopharmaceutical Co., Ltd. Recent Development Table 92. Changzhou Watson Pharmaceutical Co., Ltd. Company Information Table 93. Changzhou Watson Pharmaceutical Co., Ltd. Business Overview Table 94. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 96. Changzhou Watson Pharmaceutical Co., Ltd. Recent Development Table 97. Teva Pharmaceutical Industries Ltd. Company Information Table 98. Teva Pharmaceutical Industries Ltd. Business Overview Table 99. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio Table 101. Teva Pharmaceutical Industries Ltd. Recent Development Table 102. Sanofi Company Information Table 103. Sanofi Business Overview Table 104. Sanofi Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sanofi Leflunomide Tablets Product Portfolio Table 106. Sanofi Recent Development Table 107. Lupin Pharmaceuticals, Inc. Company Information Table 108. Lupin Pharmaceuticals, Inc. Business Overview Table 109. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio Table 111. Lupin Pharmaceuticals, Inc. Recent Development Table 112. Alembic Pharmaceuticals Inc. Company Information Table 113. Alembic Pharmaceuticals Inc. Business Overview Table 114. Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio Table 116. Alembic Pharmaceuticals Inc. Recent Development Table 117. North America Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 120. North America Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 121. North America Leflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Leflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 126. North America Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 127. North America Leflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Leflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Leflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Leflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. North America Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 134. North America Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 135. North America Leflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Leflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 138. Canada Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 139. Mexico Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 140. Europe Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 143. Europe Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 144. Europe Leflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Leflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 149. Europe Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 150. Europe Leflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Leflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Leflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Leflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 156. Europe Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 157. Europe Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 158. Europe Leflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Leflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 161. France Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 162. U.K. Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 163. Italy Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 164. Russia Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 165. Spain Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 168. Sweden Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 169. Poland Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 170. China Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 171. China Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 172. China Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 173. China Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 174. China Leflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Leflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 177. China Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 178. China Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 179. China Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 180. China Leflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Leflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 185. Asia Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 186. Asia Leflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Leflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 191. Asia Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 192. Asia Leflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Leflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Leflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Leflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 199. Asia Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 200. Asia Leflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Leflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 203. South Korea Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 204. India Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 205. Australia Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Leflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Leflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Leflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Leflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Leflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Leflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Leflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Leflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Leflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Leflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Leflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Leflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 229. Argentina Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 230. Chile Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 231. Colombia Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 232. Peru Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 234. Israel Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 235. UAE Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 236. Turkey Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 237. Iran Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 238. Egypt Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Leflunomide Tablets Distributors List Table 242. Leflunomide Tablets Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Leflunomide Tablets Image Figure 2. Global Leflunomide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leflunomide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Generic Drugs Image Figure 5. Original Drugs Image Figure 6. Global Leflunomide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Leflunomide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Leflunomide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Leflunomide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Leflunomide Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Leflunomide Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Leflunomide Tablets Sales (2021-2032) & (K Units) Figure 17. Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Leflunomide Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Leflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Leflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Leflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Leflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Leflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Leflunomide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Leflunomide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Leflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Leflunomide Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Leflunomide Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Leflunomide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Leflunomide Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Leflunomide Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Leflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Leflunomide Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Leflunomide Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Leflunomide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Leflunomide Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Leflunomide Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Leflunomide Tablets Revenue Share by Type (2021-2032) Figure 40. North America Leflunomide Tablets Sales Share by Type (2021-2032) Figure 41. North America Leflunomide Tablets Revenue Share by Application (2021-2032) Figure 42. North America Leflunomide Tablets Sales Share by Application (2021-2032) Figure 43. North America Leflunomide Tablets Revenue Share by Country (2021-2032) Figure 44. North America Leflunomide Tablets Sales Share by Country (2021-2032) Figure 45. Europe Leflunomide Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Leflunomide Tablets Sales Share by Type (2021-2032) Figure 47. Europe Leflunomide Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Leflunomide Tablets Sales Share by Application (2021-2032) Figure 49. Europe Leflunomide Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Leflunomide Tablets Sales Share by Country (2021-2032) Figure 51. China Leflunomide Tablets Revenue Share by Type (2021-2032) Figure 52. China Leflunomide Tablets Sales Share by Type (2021-2032) Figure 53. China Leflunomide Tablets Revenue Share by Application (2021-2032) Figure 54. China Leflunomide Tablets Sales Share by Application (2021-2032) Figure 55. Asia Leflunomide Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Leflunomide Tablets Sales Share by Type (2021-2032) Figure 57. Asia Leflunomide Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Leflunomide Tablets Sales Share by Application (2021-2032) Figure 59. Asia Leflunomide Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Leflunomide Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Leflunomide Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Leflunomide Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Leflunomide Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Leflunomide Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Leflunomide Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Leflunomide Tablets Sales Share by Country (2021-2032) Figure 67. Leflunomide Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Leflunomide Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drugs
  • Original Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  • Xiamen Lizhuo Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Meiro Pharmaceutical Co., Ltd.
  • Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  • Hebei Wansui Pharmaceutical Co., Ltd.
  • Fujian Huitian Biopharmaceutical Co., Ltd.
  • Changzhou Watson Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Lupin Pharmaceuticals, Inc.
  • Alembic Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Leflunomide Tablets Market by Type
  3. 1.2.1 Global Leflunomide Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Generic Drugs
  5. 1.2.3 Original Drugs
  6. 1.3 Leflunomide Tablets Market by Application
  7. 1.3.1 Global Leflunomide Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Leflunomide Tablets Market Dynamics
  1. 2.1 Leflunomide Tablets Industry Trends
  2. 2.2 Leflunomide Tablets Industry Drivers
  3. 2.3 Leflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Leflunomide Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Leflunomide Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Leflunomide Tablets Revenue by Region
  3. 3.2.1 Global Leflunomide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Leflunomide Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Leflunomide Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Leflunomide Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Leflunomide Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Leflunomide Tablets Sales by Region
  9. 3.4.1 Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Leflunomide Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Leflunomide Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Leflunomide Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Leflunomide Tablets Revenue by Manufacturers
  2. 4.1.1 Global Leflunomide Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Leflunomide Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Leflunomide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Leflunomide Tablets Sales by Manufacturers
  6. 4.2.1 Global Leflunomide Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Leflunomide Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Leflunomide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Leflunomide Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Leflunomide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Leflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Leflunomide Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Leflunomide Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Leflunomide Tablets Market CR5 and HHI
  16. 4.8.2 2025 Leflunomide Tablets Tier 1, Tier 2, and Tier 3
5 Leflunomide Tablets Market by Type
  1. 5.1 Global Leflunomide Tablets Revenue by Type
  2. 5.1.1 Global Leflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Leflunomide Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Leflunomide Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Leflunomide Tablets Sales by Type
  6. 5.2.1 Global Leflunomide Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leflunomide Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Leflunomide Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Leflunomide Tablets Price by Type
6 Leflunomide Tablets Market by Application
  1. 6.1 Global Leflunomide Tablets Revenue by Application
  2. 6.1.1 Global Leflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Leflunomide Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Leflunomide Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Leflunomide Tablets Sales by Application
  6. 6.2.1 Global Leflunomide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Leflunomide Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Leflunomide Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Leflunomide Tablets Price by Application
7 Company Profiles
  1. 7.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  2. 7.1.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  6. 7.1.5 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Xiamen Lizhuo Pharmaceutical Co., Ltd.
  8. 7.2.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  12. 7.2.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Qilu Pharmaceutical Co., Ltd.
  14. 7.3.1 Qilu Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Meiro Pharmaceutical Co., Ltd.
  20. 7.4.1 Meiro Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Meiro Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  24. 7.4.5 Meiro Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  26. 7.5.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  30. 7.5.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Hebei Wansui Pharmaceutical Co., Ltd.
  32. 7.6.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Hebei Wansui Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  36. 7.6.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Fujian Huitian Biopharmaceutical Co., Ltd.
  38. 7.7.1 Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  42. 7.7.5 Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Changzhou Watson Pharmaceutical Co., Ltd.
  44. 7.8.1 Changzhou Watson Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Changzhou Watson Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  48. 7.8.5 Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Teva Pharmaceutical Industries Ltd.
  50. 7.9.1 Teva Pharmaceutical Industries Ltd. Company Information
  51. 7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  52. 7.9.3 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  55. 7.10 Sanofi
  56. 7.10.1 Sanofi Company Information
  57. 7.10.2 Sanofi Business Overview
  58. 7.10.3 Sanofi Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Leflunomide Tablets Product Portfolio
  60. 7.10.5 Sanofi Recent Developments
  61. 7.11 Lupin Pharmaceuticals, Inc.
  62. 7.11.1 Lupin Pharmaceuticals, Inc. Company Information
  63. 7.11.2 Lupin Pharmaceuticals, Inc. Business Overview
  64. 7.11.3 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio
  66. 7.11.5 Lupin Pharmaceuticals, Inc. Recent Developments
  67. 7.12 Alembic Pharmaceuticals Inc.
  68. 7.12.1 Alembic Pharmaceuticals Inc. Company Information
  69. 7.12.2 Alembic Pharmaceuticals Inc. Business Overview
  70. 7.12.3 Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio
  72. 7.12.5 Alembic Pharmaceuticals Inc. Recent Developments
8 North America
  1. 8.1 North America Leflunomide Tablets Market Size by Type
  2. 8.1.1 North America Leflunomide Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Leflunomide Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Leflunomide Tablets Price by Type (2021-2032)
  5. 8.2 North America Leflunomide Tablets Market Size by Application
  6. 8.2.1 North America Leflunomide Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Leflunomide Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Leflunomide Tablets Price by Application (2021-2032)
  9. 8.3 North America Leflunomide Tablets Market Size by Country
  10. 8.3.1 North America Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Leflunomide Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Leflunomide Tablets Market Size by Type
  2. 9.1.1 Europe Leflunomide Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Leflunomide Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Leflunomide Tablets Price by Type (2021-2032)
  5. 9.2 Europe Leflunomide Tablets Market Size by Application
  6. 9.2.1 Europe Leflunomide Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Leflunomide Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Leflunomide Tablets Price by Application (2021-2032)
  9. 9.3 Europe Leflunomide Tablets Market Size by Country
  10. 9.3.1 Europe Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Leflunomide Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Leflunomide Tablets Market Size by Type
  2. 10.1.1 China Leflunomide Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Leflunomide Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Leflunomide Tablets Price by Type (2021-2032)
  5. 10.2 China Leflunomide Tablets Market Size by Application
  6. 10.2.1 China Leflunomide Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Leflunomide Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Leflunomide Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Leflunomide Tablets Market Size by Type
  2. 11.1.1 Asia Leflunomide Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Leflunomide Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Leflunomide Tablets Price by Type (2021-2032)
  5. 11.2 Asia Leflunomide Tablets Market Size by Application
  6. 11.2.1 Asia Leflunomide Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Leflunomide Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Leflunomide Tablets Price by Application (2021-2032)
  9. 11.3 Asia Leflunomide Tablets Market Size by Country
  10. 11.3.1 Asia Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Leflunomide Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Leflunomide Tablets Market Size by Type
  2. 12.1.1 SAMEA Leflunomide Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Leflunomide Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Leflunomide Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Leflunomide Tablets Market Size by Application
  6. 12.2.1 SAMEA Leflunomide Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Leflunomide Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Leflunomide Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Leflunomide Tablets Market Size by Country
  10. 12.3.1 SAMEA Leflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Leflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Leflunomide Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Leflunomide Tablets Value Chain Analysis
  2. 13.1.1 Leflunomide Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Leflunomide Tablets Production Mode & Process
  6. 13.2 Leflunomide Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Leflunomide Tablets Distributors
  9. 13.2.3 Leflunomide Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst